Suchergebnisse - "Bergot, Emmanuel"

PubPharm (7)

1

NDR2 kinase contributes to cell invasion and cytokinesis defects induced by the inactivation of RASSF1A tumor-suppressor gene in lung cancer cells

enthalten in: Journal of experimental & clinical cancer research : CR | 2019

von Keller, M. | Dubois, F. | Teulier, S. | +10

2

Predictive biomarkers in patients with resected non-small cell lung cancer treated with perioperative chemotherapy

enthalten in: European respiratory review : an official journal of the European Respiratory Society | 2013

von Bergot, E. | Levallet, G. | Campbell, K. | +3

3

An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2012

von de Fraipont, F. | Levallet, G. | Creveuil, C. | +118

4

High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway

enthalten in: Molecular cancer therapeutics | 2012

von Levallet, G. | Bergot, E. | Antoine, M. | +18

5

A STEPP too far for FLEX?

enthalten in: The Lancet. Oncology | 2012

von Bergot, E. | Creveuil, C. | Zalcman, G.

CommentOn: Lancet Oncol. 2012 Jan;13(1):33-42. - PMID 22056021

6

Integrating biomarkers into clinical trials : methodological issues for a new paradigm in nonsmall cell lung cancer

enthalten in: Current opinion in oncology | 2011

von Zalcman, G. | Bergot, E. | Creveuil, C. | +2

7

Gefitinib plus docetaxel in non-small-cell lung cancer

enthalten in: Lancet (London, England) | 2009

von Zalcman, G. | Bergot, E.

CommentOn: Lancet. 2008 Nov 22;372(9652):1809-18. - PMID 19027483

1
[1]